Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McManus

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Journal of Medicinal Chemistry|April 11, 2017
Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 ChannelsChunrong Qu, Mingmin Ding, Yingmin Zhu, et al.
Journal of Plankton Research|July 24, 2023
Mixoplankton and mixotrophy: future research prioritiesNicole C Millette, Rebecca J Gast, Jessica Y Luo, et al.
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile SulfonamidePengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Cellular Immunology|December 23, 1999
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channelsG C Koo, J T Blake, K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.
Journal of Medicinal Chemistry|October 27, 2012
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic painPengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Cell Biochemistry and Biophysics|July 8, 2009
Positive allosteric interaction of structurally diverse T-type calcium channel antagonistsVictor N Uebele, Cindy E Nuss, Steven V Fox, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Journal of Medicinal Chemistry|April 11, 2017
Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 ChannelsChunrong Qu, Mingmin Ding, Yingmin Zhu, et al.
Journal of Plankton Research|July 24, 2023
Mixoplankton and mixotrophy: future research prioritiesNicole C Millette, Rebecca J Gast, Jessica Y Luo, et al.
Biochemistry|June 12, 2002
Identification of a new class of inhibitors of the voltage-gated potassium channel, Kv1.3, with immunosuppressant propertiesWilliam A Schmalhofer, Jianming Bao, Owen B McManus, et al.
Molecular Pharmacology|November 23, 2005
Block of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsRichard M Brochu, Ivy E Dick, Jason W Tarpley, et al.
Diabetes|March 29, 2006
Blockers of the delayed-rectifier potassium current in pancreatic beta-cells enhance glucose-dependent insulin secretionJames Herrington, Yun-Ping Zhou, Randal M Bugianesi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile SulfonamidePengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Cellular Immunology|December 23, 1999
Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channelsG C Koo, J T Blake, K Shah, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
A potent and selective indole N-type calcium channel (Ca(v)2.2) blocker for the treatment of painSriram Tyagarajan, Prasun K Chakravarty, Min Park, et al.
Journal of Medicinal Chemistry|October 27, 2012
Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic painPengcheng P Shao, Feng Ye, Prasun K Chakravarty, et al.
Cell Biochemistry and Biophysics|July 8, 2009
Positive allosteric interaction of structurally diverse T-type calcium channel antagonistsVictor N Uebele, Cindy E Nuss, Steven V Fox, et al.
Pageof 18